Engrail Therapeutics
San Diego
About Engrail Therapeutics
Engrail is forging a new direction to reduce the enormous burden of diseases that impact the nervous system. We unite biological insights with clinically meaningful solutions to build and catalyze a diversified portfolio of transformative medicines. Harnessing our rigorous scientific approach to identify the most promising therapies, we leverage our flexible transaction model to advance assets with validated mechanisms and efficiently move them through development to commercialization.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $221.0M
- Funding stage: Early Stage Venture
- Last round: Series B (Mar 2024)
- Website: engrail.com
- Phone: [email protected]
Industries & Categories
Health Care, Life Science, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/engrail-therapeutics-57493 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.